5 Healthcare Stocks to Buy According to Lee Ainslie’s Maverick Capital

2. Seer, Inc. (NASDAQ:SEER)

Maverick Capital’s Stake Value: $187 million

Percentage of Maverick Capital’s 13F Portfolio: 1.88%

Number of Hedge Fund Holders: 11

Seer, Inc. (NASDAQ:SEER) is a backend life sciences company that aims to let its customers extract information from biological systems. Its products cover several areas such as proteomics which is the large-scale study of proteins and their constituent structures.

As Q3 2021 came to an end, Maverick Capital owned 5.4 million Seer, Inc. (NASDAQ:SEER) shares in a $187 million stake constituting 1.88% of its portfolio. Insider Monkey’s survey of 867 hedge funds for the third quarter of this year revealed that 11 funds held a stake in the company.

Seer, Inc. (NASDAQ:SEER)’s revenue and GAAP EPS for its fiscal Q3 stood at $2 million and -$0.30, respectively, as it only beat revenue estimates.

Seer, Inc. (NASDAQ:SEER)’s largest investor after Maverick Capital is Efrem Kamen’s Pura Vida Investments who owns 857,306 shares worth $29 million.